Abstract
Cannabis is the most widely used recreational drug in the world. Cannabis has euphorigenic and anxiolytic properties. Smoking is the most efficient means of delivering cannabis to the central nervous system, where the dose may be titrated by adjusting the frequency and depth of inhalation. Medical application of cannabis is controversial and illegal in most countries. Cannabis is not approved as a medication by the United States Food and Drug Administration. However, some states permit medical treatment with low-dose synthetic cannabinoids for management of pain and nausea in chronically ill patients. Methods for administration include ingestion of extracts or oral capsules, smoking, or inhalation of vaporized fumes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Ashton C. Pharmacology and effects of cannabis: a brief review. Br J Psychiatry. 2001;178:101–6.
Ducros A, Brousser MG. Reversible cerebral vasoconstriction syndrome. Pract Neurol. 2009;9:256–67.
Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Brousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective of 67 patients. Brain. 2007;130:3091–101.
Hazouard E, Koninck JC, Attucci S, Fauchier-Rolland F, Brunereau L, Diot P. Pneumorachis and pneumomediastinum caused by repeated Müller’s maneuvers: complications of marijuana smoking. Ann Emerg Med. 2001;38(6):694–7.
Iversen L. Invited review: cannabis and the brain. Brain. 2003;126:1252–70.
Lupica C, Riegel A, Hoffman A. Mini review: marijuana and cannabinoid regulation of brain reward circuits. Br J Pharmacol. 2004;143:227–34.
MartÃn-Santos R, Fagundo AB, Crippa JA, Atakan Z, Bhattacharyya S, Allen P, Fusar-Poli P, Borgwardt S, Seal M, Busatto GF, McGuire P. Neuroimaging in cannabis use: a systematic review of the literature. Psychol Med. 2010;40(3):383–98.
Wilson W, Mathew R, Turkington T, Hawk T, Coleman RE, Provenzale J. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. J Addict Dis. 2000;19(1):1–22.
Wolff V, Armspach JP, Lauer V, Rouyer O, Bataillard M, Marescaux C, Geny B. Cannabis-related stroke: myth or reality? Stroke. 2013;44(2):558–63.
Yucel M, Solowij N, Respondek C, Whittle S, Fornito A, Pantelis C, Lubman D. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry. 2008;65(6):694–701.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Ang, E.C., Stuckey, S.L., Ginat, D.T., Chandra, R.V. (2015). Cannabis (Marijuana). In: Ginat, D., Small, J., Schaefer, P. (eds) Neuroimaging Pharmacopoeia. Springer, Cham. https://doi.org/10.1007/978-3-319-12715-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-12715-6_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12714-9
Online ISBN: 978-3-319-12715-6
eBook Packages: MedicineMedicine (R0)